Pharvaris - PHVS Net Assets per Single Share
Pharvaris N.V. (PHVS) specializes in developing oral treatments for rare hereditary angioedema, which creates niche specialization risks but eliminates competition. This price chart illustrates the asset's dynamics, where the indicator stands at 4.86. Since the company is based in Europe while conducting tests in the US, the cross-border transport of biomaterials remains vulnerable to geopolitical shocks and sanction restrictions.
pharvaris.com - analytical breakdowns and key metrics (PHVS)
- price and consensus price forecast:
- market capitalization data:
- book capitalization data:
- debt and liquidity data:
Fundamental company valuation:Pharvaris Corp - PHVS
Investors must assess the capital preservation of Pharvaris N.V. (PHVS) to minimize asset ownership risks. Stable cash flow from orphan disease therapies ensures high operational resilience for the business. The book value per share metric reflects the volume of net assets per security after deducting all liabilities. The dynamics of this metric allow for stress-testing the company's balance sheet for resilience against external shocks. The growing trend confirms the issuer's fundamental reliability and capitalization.
Competitors of Pharvaris N.V. (PHVS)
ARGX - Accounting Value per Share|BNTX: Net Assets per Single Share|Abivax Corp - Net Assets per Single Share|ADMA (admabiologics.com) - Net Assets per Share|Net Assets per Single Share Protagonist PTGX|Share Book Value Immunovant Inc|Kiniksa Pharmaceuticals Ltd (KNSA) - Book Value per Share|Accounting Value of a Share Grifols Biemat (GRFS)|Book Value per Share ADPT (Adaptive Biotechnologies)|celldex.com - Book Value per Share|Net Assets per Single Share Aurinia Pharmaceuticals Inc. (AUPH)|BCRX: Accounting Value of a Share|VERA (Vera Pharma) - Net Assets per Single Share|Dianthus Corp (DNTH) - Accounting Value per Share|ABCL (AbCellera Biologics Inc) - Book Value per Share|Book Value per Share tourmalinebio.com (TRML)|Precigen (PGEN) - Accounting Value per Share|Accounting Value of a Share Pharming Group NV (PHAR)|Book Value per Share NKTR|Upstream Pharma - Net Assets per Share|ZBIO: Net Assets per Single Share|IMNM: Accounting Value per Share|GOSS (Gossamer Bio) - Net Assets per Single Share|Accounting Value per Share KalVista Pharma|SEPN (Septerna Corp) - Accounting Value per Share|Book Value per Share PVLA|Net Assets per Single Share Savara Inc. SVRA|Equity per Share rigel.com (RIGL)|ANAB: Book Value per Share|Astria Therapeutics Inc - Net Asset Value per Share|Net Assets per Single Share enGene Bio|RAPT - Share Book Value|Book Value per Share aerovatetx.com JBIO|aclaristx.com (ACRS) - Accounting Value of a Share|KYTX (Kyverna Therapeutics, Inc.) - Book Value per Share|Book Value per Share TLSA|Cabaletta Bio, Inc (CABA) - Net Assets per Single Share|Accounting Value of a Share Ventyx Biosciences, Inc VTYX|Accounting Value per Share Theratechnologies Inc. THTX|Net Assets per Single Share avalotx.com AVTX|Eledon Pharmaceuticals, Inc. - Book Value per Share|AGEN: Book Value per Share|Net Assets per Single Share Climb Bio, Inc. CLYM|Zura Bio Ltd (ZURA) - Accounting Value of a Share|ATYR: Book Value per Share|Net Assets per Share ADAG|IMA (ImageneBio Inc) - Net Assets per Single Share|Net Assets per Share shattucklabs.com STTK|Accounting Value per Share Equillium|Connect Biopharma Holdings - Accounting Value of a Share|Immunic Inc (IMUX) - Net Assets per Single Share|Atara Biotherapeutics (ATRA) - Equity per Share|inflarx.de - Accounting Value per Share|Net Assets per Share X4 Pharmaceuticals Inc.|Accounting Value per Share Adicet Bio Inc.|Net Assets per Single Share Celularity Corp (CELU)|INMB (INmune Bio, Inc.) - Accounting Value per Share|Net Assets per Share BRNS (barinthusbio.com)|Kezar Life Sciences, Inc. (KZR) - Net Assets per Single Share|Share Book Value SAB Biotherapeutics Inc. SABS|Book Value per Share Akari Therapeutics plc (AKTX)|Enlivex Therapeutics (ENLV) - Accounting Value of a Share|q32bio.com (QTTB) - Accounting Value per Share|GOVX (geovax.com) - Net Assets per Single Share|EDSA: Net Assets per Single Share|Net Assets per Share IBIO|CARM - Net Assets per Single Share|Share Book Value XTL Bio (XTLB)|Book Value per Share Bolt Biotherapeutics, Inc.|Accounting Value of a Share HCW Biologics, Inc. HCWB|Aptevo - Book Value per Share|AIM: Book Value per Share|Net Assets per Single Share aditxt.com ADTX|GRI (GRI Bio Corporation) - Accounting Value of a Share|Net Assets per Single Share XRTX|Accounting Value per Share reshapelifesciences.com|Book Value per Share REVB|Book Value per Share Indaptus Therapeutics Inc INDP|Accounting Value per Share Scinai|Accounting Value of a Share CalciMedica Inc CALI|Book Value per Share AFMD (Affimed Therapeutics)|ALLK: Net Assets per Share|HOOK (hookipapharma.com) - Net Assets per Single Share|IGMS (IGM Biosciences) - Accounting Value per Share|Net Assets per Single Share ITOS|Accounting Value per Share Ocean Biomedical Corp (OCEA)|Accounting Value per Share TCBP|Book Value per Share THRD (thirdharmonicbio.com)